Furthermore, EGCC inhibited the metastasis of ovarian cancer cells by inhibiting the phosphorylation of c-Jun and NF-κB, resulting in the decreased expression of VEGF and the secretion of MMP-2 and MMP-9. The gene discussed is MMP2; the disease is ovarian carcinoma.